145 results on '"De Rosa, Luca"'
Search Results
2. Dual spaces of geodesic currents
3. Design and assessment of energy infrastructure in new decarbonized urban districts: A Spanish case study
4. Testing and validating AnTraGoS algorithms with impact beating spatters
5. Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
6. Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
7. Forecasting and assessment of the 2030 australian electricity mix paths towards energy transition
8. Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for T Cell Acute Lymphoblastic Leukemia: A Report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
9. Long Term Survival in Multiple Myeloma Patients: A Multicenter Italian Experience
10. Another Example of a Data Warehouse System Based on Transposed Files
11. Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group
12. Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
13. Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
14. Consolidation Treatment with VRD Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Trial of the European Myeloma Network (EMN02/HO95)
15. MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients
16. Hemopoietic Recovery and Infectious Complications in Breast Cancer and Multiple Myeloma after Autologous CD34+ Cell-Selected Peripheral Blood Progenitor Cell Transplantation
17. Impact of Minimal Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) on Outcome: Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients Enrolled in the Forte Trial
18. Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form
19. Early Observations on the Steamer Bengala (Formerly Named Mecca and Livorno) Sunk off Capo Rizzuto (Crotone, Italy) in 1889
20. Integrative Analysis of Baseline Prognostic Features and Achievement of Minimal Residual Disease Negativity As Predictors of Early Relapse in Transplant-Eligible Multiple Myeloma Patients
21. Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial
22. Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma.
23. Tandem high dose chemotherapy (HDC) with peripheral blood progenitors cells (PBPC) support following induction chemotherapy in metastatic breast cancer
24. INTERMEDIATE-HIGH RISK B-CELL NON HODGKIN'S LYMPHOMA UNDERWENT NEGATIVE IMMUNOMAGNETIC PURGED AUTOLOGOUS BONE MARROW TRANSPLANTATION IN FIRST COMPLETE REMISSION: LONG TERM RESULTS
25. Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
26. Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
27. Immunotherapy in Multiple Myeloma: Experience of the Multiple Myeloma Gimema Lazio Group
28. Cyclophosphamide’s addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment
29. Consolidation Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Study of the European Myeloma Network (EMN02/HO95 MM Trial)
30. Virtual Karyotype Reconstruction By SNPs Array of Newly Diagnosed Multiple Myeloma (MM) Patients Enrolled in the EMN02 Clinical Trial
31. Currents in Teichmüller Theory and Their Dual Spaces
32. Long-Term Molecular Results Of The Gimema VEL-03-096 Trial: Molecular Remission Achievement and Loss Are Major Outcome Predictors
33. A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients
34. Autologous Peripheral Blood Stem-Cell (PBSC) Collection Is Not Impaired by Bortezomib-Thalidomide-Dexamethasone (VTD) Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)
35. LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL
36. Bortezomib, Melphalan, Prednisone and Thalidomide Followed by Maintenance with Bortezomib and Thalidomide (VMPT-VT) for Initial Treatment of Elderly Multiple Myeloma Patients: Updated Follow-up and Impact of Prognostic Factors
37. Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
38. Sequential Approach with Bortezomib as Induction Before Autologous Transplantation, Followed by Lenalidomide as Consolidation-Maintenance in Untreated Multiple Myeloma Patients.
39. Correlation Between Clinical Outcome and Disease Kinetics by Quantitative PCR in Myeloma Patients Following Post-Transplant Consolidation with Bortezomib, Thalidomide and Dexamethasone.
40. Indoleamine 2,3-Dioxygenase (IDO) Is Expressed by Multiple Myeloma Plasma Cells and Promotes the Differentiation of Regulatory T Cells: Investigations into the Role of Hepatocyte Growth Factor.
41. Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients.
42. Efficacy of Imatinib Mesylate in a Patient with Idiopathic Hypereosinophilic Syndrome and Severe Heart Involvement
43. Successful paternity with microassisted fertilization after total body irradiation-based conditioning for autologous bone marrow transplantation
44. Immune Recovery in Breast Cancer Patients after Tandem High-Dose Chemotherapy Rescued by Selected CD34+Cells
45. Nondestructive technique based on vibration measurements and piezoelectric patches for monitoring corrosion phenomena
46. Nondestructive technique based on vibration measurements and piezoelectric patches for monitoring corrosion phenomena.
47. Detection of Breast Cancer Cells in the Bone Marrow or Peripheral Blood: Methods and Prognostic Significance
48. Recombinant Interleukin-2 Treatment Before and After Autologous Stem Cell Transplantation in Hematologic Malignancies: Clinical and Immunologic Effects
49. Pater pauperum. Francesco, Assisi e l'elemosina.
50. OAB-004: Carfilzomib-based induction/consolidation with or without autologous transplant and Lenalidomide (R) or Carfilzomib-Lenalidomide (KR) maintenance: efficacy in high-risk patients of the FORTE study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.